MSS/ MMRp

Who we are

  • October 15, 2024
    Phase 2 Study of SR-8541A in Combination With Botensilimab and Balstilimab in Subjects With Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)
  • October 14, 2024
    A Study of AK112 With or Without AK117 in Metastatic Colorectal Cancer
  • August 23, 2024
    A Dose Escalation Study of AV-380 in Metastatic Cancer Patients With Cachexia
  • July 29, 2024
    A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Solid Tumors
  • July 29, 2024
    HRYZ-T102 TCR-T Cell for AFP Positive Advanced HCC and Other Solid Tumors
  • June 28, 2024
    Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer
  • June 23, 2024
    Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors (PROCEADE-CRC-01)
  • May 17, 2024
    Low and Intermediate Risk oliGometastatic coloREctal cancEr patieNts Treated With Stereotactic ABlative Radiotherapy
  • April 24, 2024
    Platform Study of Immunotherapy Combinations in Colorectal Cancer Liver Metastases
  • April 24, 2024
    MSLN-targeted CAR-T Cells in Solid Tumors.